Medical University of Ohio Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2003
NCT00230191
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Alternative names

Medical University of Ohio Cancer Center